Clinical trial
Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent
NCT00415805 · Bracco Diagnostics, Inc, Industry · Completed
Key facts
| NCT number | NCT00415805 |
|---|---|
| Title | Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent |
| Official title | A Pilot, Open-label, Multicenter Intra-individual Comparison of Multihance and Vasovist for Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) of Renal Arteries |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Steno-occlusive Disease |
| Intervention type | Drug |
| Interventions | Multihance, vasovist |
| Enrollment | 39 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Dec 25, 2006 |
| Last update posted | Aug 1, 2023 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: